OsNovum Revenue

Biotechnology Research • 1051 Olsen St, 3611, United States • 1-10 Employees

OsNovum revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at OsNovum

Roslynn Steiner

Chief Executive Officer

Company overview

Headquarters	1051 Olsen St, 3611, Henderson, Nevada 89011, US
Website	osnovum.com
NAICS	541714
Keywords	Biotechnology And Regenerative Medicine
Founded	2020
Employees	1-10

About OsNovum

At OsNovum, we are pioneering a precision approach to develop regenerative therapies designed to transform the lives of patients with osteoporotic conditions. While there are many drugs available on the market for osteoporosis treatment, they frequently cause significant side effects and patients often refuse treatment to avoid those adverse systemic effects. Our solution approaches the treatment of weak and frail bone in a very different manner. Our technology has been FDA-cleared and on the market for years regenerating maxillofacial bone thanks to decades of vigorous research and development offered by our founders through SteinerBio. OsNovum is now taking this regenerative material, which converts poorly mineralized bone into dense, healthy tissue, to the skeleton through a local application into an areas of weakened bone. OsNovum is adopting this innovative technology to address osteoporosis and regenerate weakened bones before they have a chance to fracture, creating a lasting impact on so many lives.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

OsNovum has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

OsNovum has never raised funding before.

Frequently asked questions

OsNovum is located in 1051 Olsen St, 3611, US.

OsNovum generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

OsNovum has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

OsNovum was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

OsNovum has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at OsNovum

Roslynn Steiner

Chief Executive Officer

4.8

40,000 users